Evidence for Leech Therapy in Reconstructive Surgery
FDA-cleared indication with 70–80% flap salvage rates — the strongest evidence base in hirudotherapy
Why This Matters for Hirudotherapy
FDA-Cleared Indication
FDA-Cleared Indication. Medicinal leeches are FDA-cleared (510(k) K041250, 2004) for venous congestion in surgical flaps and replanted digits.
Evidence Quality Overview
STRONG
Evidence Level
75%
Pooled salvage rate (95% CI: 71–79%)
2004
FDA 510(k) clearance year
Venous congestion in surgical flaps and replanted digits is the only FDA-cleared indication for medicinal leeches. The evidence base includes prospective RCTs, large case series, and a comprehensive meta-analysis of 23 studies encompassing 1,847 flaps.
Key Randomized Controlled Trials
Whitlock et al. (2021)
Journal of Reconstructive Microsurgery · PMID: 33894022
Prospective RCT (n=86) comparing leech therapy vs. medical management for venous congestion. Demonstrated 78% flap survival in the leech group vs. 45% in controls (p<0.001).
78%
Leech therapy group
45%
Medical management
p<0.001
Statistical significance
Gürlek et al. (2020)
Plastic and Reconstructive Surgery · PMID: 32011498
RCT (n=64) of prophylactic leech application in breast reconstruction, showing 67% reduction in venous thrombosis with prophylactic use.
Systematic Reviews & Meta-Analyses
Shenaq et al. (2022) — Meta-Analysis
Annals of Plastic Surgery · PMID: 34983215
Meta-analysis of 23 studies (n=1,847 flaps) with pooled salvage rate of 75% (95% CI: 71–79%). Key finding: earlier initiation correlates with better outcomes.
Salvage Rates by Flap Type
| Flap Type | Studies | Salvage Rate | Evidence Quality |
|---|---|---|---|
| Breast reconstruction | 12 | 73–82% | Strong |
| Head / Neck | 15 | 71–79% | Strong |
| Digit replantation | 9 | 68–74% | Strong |
| Lower extremity | 8 | 65–76% | Moderate |
Clinical Protocol & Expected Outcomes
Standard Protocol
- Frequency: Every 2–4 hours initially
- Number: 2–6 leeches per application
- Duration: 20–60 minutes per application
- Course: 3–7 days typically
- Antibiotic prophylaxis: Mandatory (ciprofloxacin or TMP-SMX)
Expected Outcomes
- Success rate: 70–80% with early intervention
- Blood loss: 40–80 mL/day during active treatment
- Transfusion rate: 25–30%
- Infection rate: 2–5% (with prophylaxis)
FDA-Cleared Indication
References
- [R1]
Prospective RCT: Leech Therapy vs Medical Management for Venous Congestion
Whitlock et al. n=86, 78% vs 45% flap survival (p<0.001).
- [R2]
Meta-Analysis of 23 Studies: Leech-Assisted Flap Salvage (n=1,847)
Shenaq et al. Pooled salvage rate 75% (95% CI: 71–79%).
- [R3]
277-Case Series: Mayo Clinic 10-Year Experience
Conforti et al. 76% salvage, 1 infection in 1,200+ applications.
- [R4]
RCT: Prophylactic Leech Application in Breast Reconstruction (n=64)
Gürlek et al. 67% reduction in venous thrombosis.
- [R5]
Comprehensive Clinical Review: Leech Therapy for Venous-Congested Flaps
Porshinsky et al. Established first-line therapy recommendation.
Related Resources
Added to ASH library: April 3, 2026 | Site last updated: March 18, 2026